Pediatric genitourinary tumors
Authors:
- Thomas W McLeanTMThomas W McLean
- Sharon M CastellinoSCSharon M Castellino
- 1 May 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 20 (3) , 315-320
Abstract
We will review the recent (2006/2007) literature on pediatric genitourinary tumors. The WTX gene is now the most common known gene mutation in Wilms' tumor. It acts as a tumor suppressor gene and may play a role in other malignancies. Current clinical trials have incorporated the loss of heterozygosity of 1p and 16q along with age, tumor size, stage, and response to therapy to risk stratify therapy. The PAX3-FOX01 gene fusion and the IGF-1R-signaling and mTOR-signaling pathways are implicated in rhabdomyosarcoma biology, and hence are promising therapeutic targets for this tumor. Progress is being made in understanding the pathogenesis of genitourinary tumors in children, and the prognosis for these children continues to improve. Current treatment strategies are focused on improving event-free survival while decreasing late effects from therapy.Keywords
This publication has 58 references indexed in Scilit:
- Controversies in the management of Wilms tumour – Immediate nephrectomy or delayed nephrectomy?European Journal of Cancer, 2007
- Wilms tumour: prognostic factors, staging, therapy and late effectsPediatric Radiology, 2007
- Bilateral disease and new trends in Wilms tumourPediatric Radiology, 2007
- Transatlantic controversies in the treatment of Wilms’ tumourEuropean Journal of Cancer, 2007
- Renal Function Outcomes in Patients Treated With Nephron Sparing Surgery for Bilateral Wilms TumorJournal of Urology, 2007
- The use of preoperative chemotherapy in Wilms' tumor with contained retroperitoneal ruptureJournal of Pediatric Surgery, 2007
- Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: A report from the National Wilms Tumor Study GroupPediatric Blood & Cancer, 2007
- FURTHER EXPERIENCE WITH LAPAROSCOPIC NEPHRECTOMY FOR WILMS’ TUMOUR AFTER CHEMOTHERAPYBJU International, 2006
- Breast-feeding and Wilms Tumor: A Report from the Children’s Oncology GroupCancer Causes & Control, 2006
- Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study GroupJournal of Clinical Oncology, 2005